Meng‐Fen Wu

1.6k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Meng‐Fen Wu is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Meng‐Fen Wu has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Immunology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Meng‐Fen Wu's work include CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (6 papers). Meng‐Fen Wu is often cited by papers focused on CAR-T cell therapy research (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Immune Cell Function and Interaction (6 papers). Meng‐Fen Wu collaborates with scholars based in United States, Switzerland and Russia. Meng‐Fen Wu's co-authors include Helen E. Heslop, Stephen Gottschalk, Malcolm K. Brenner, Catherine M. Bollard, Adrian P. Gee, Cliona M. Rooney, George Carrum, Hao Liu, Vicky Torrano and Heidi L. Weiss and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Meng‐Fen Wu

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

2013 384 citations Catherine M. Bollard, Stephen Gottschalk et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Meng‐Fen Wu

Since Specialization

Citations

This map shows the geographic impact of Meng‐Fen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Fen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Fen Wu more than expected).

Fields of papers citing papers by Meng‐Fen Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Fen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Fen Wu. The network helps show where Meng‐Fen Wu may publish in the future.

Co-authorship network of co-authors of Meng‐Fen Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Fen Wu. A scholar is included among the top collaborators of Meng‐Fen Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Fen Wu. Meng‐Fen Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors 2024 ·Cytotherapy ·(unknown), (unknown), Tao Wang, Meng‐Fen Wu, (unknown), Thomas Pfeiffer, Shoba A. Navai, Andras Heczey, Meenakshi Hegde, Nabil Ahmed, Sarah Burkhead Whittle, LaQuisa Hill, Caridad Martinez, Robert A. Krance, Carlos A. Ramos, Rayne H. Rouce, Premal Lulla, Helen E. Heslop, Bilal Omer, (unknown)	0
2	Glypican-3–Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma 2020 ·Cancer Immunology Research ·(unknown), Purva Rathi, Linjie Guo, Amy N. Courtney, Julien Fleurence, Julien Balzeau, Rahamthulla S. Shaik, Thao P. Nguyen, Meng‐Fen Wu, (unknown), Maksim Mamonkin, Leonid S. Metelitsa, Andras Heczey	193
3	Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 ⁺ T cells 2020 ·Science Advances ·Jan A. Rath, Gagan Bajwa, Benoît M. Carrères, (unknown), Isabelle Gruber, Melisa Martinez-Paniagua, Yi-Ru Yu, Nazila Nouraee, Fatemeh Sadeghi, Meng‐Fen Wu, Tao Wang, Michaël Hebeisen, Nathalie Rufer, Navin Varadarajan, Ping‐Chih Ho, Malcolm K. Brenner, David Gfeller, Caroline Arber	23
4	Engineering oncolytic vaccinia virus to redirect macrophages to tumor cells 2020 ·PubMed ·(unknown), Phuong Nguyen, Bangxing Hong, Christopher DeRenzo, Nino Rainusso, (unknown), Meng‐Fen Wu, Hao Liu, Xiao‐Tong Song, Masataka Suzuki, Lisa L. Wang, Jason T. Yustein, Stephen Gottschalk	13
5	The alternative complement pathway activation product Ba as a marker for transplant‐associated thrombotic microangiopathy 2019 ·Pediatric Blood & Cancer ·Sarah E. Sartain, (unknown), Meng‐Fen Wu, Tao Wang, Caridad Martinez	17
6	Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients 2019 ·Blood Advances ·Swati Naik, Caridad Martinez, Bilal Omer, Ghadir Sasa, (unknown), Carl E. Allen, Kala Y. Kamdar, Robert C. Orth, Meng‐Fen Wu, Kathryn Leung, Stephen Gottschalk, Malcolm K. Brenner, Helen E. Heslop, Robert A. Krance	6
7	EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation 2018 ·Blood ·Lauren P. McLaughlin, Rayne H. Rouce, Stephen Gottschalk, Vicky Torrano, George Carrum, Meng‐Fen Wu, Fahmida Hoq, Bambi Grilley, (unknown), Patrick J. Hanley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard	56
8	CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells 2017 ·Cancer Immunology Research ·Mireya Paulina Velasquez, Árpád Szöőr, Abishek Vaidya, (unknown), Phuong Nguyen, Meng‐Fen Wu, Hao Liu, Stephen Gottschalk	28
9	c-MPL provides tumor-targeted T-cell receptor-transgenic T cells with costimulation and cytokine signals 2017 ·Blood ·(unknown), Daniel Brenner, Malini Mukherjee, Rachel Hirsch, (unknown), Meng‐Fen Wu, Hao Liu, Olga Dakhova, Jordan S. Orange, Malcolm K. Brenner, Charles Y. Lin, Caroline Arber	9
10	Administration of LMP-specific cytotoxic T-lymphocytes to patients with relapsed EBV-positive lymphoma post allogeneic stem cell transplant 2015 ·Cytotherapy ·(unknown), Serena Perna, Stephen Gottschalk, George Carrum, (unknown), Oumar Diouf, Meng‐Fen Wu, Robert A. Krance, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Catherine M. Bollard	2
11	A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children's Oncology Group study 2015 ·British Journal of Haematology ·Terzah M. Horton, Richard A. Drachtman, Lu Chen, Peter D. Cole, Kathleen M. McCarten, Stephan D. Voss, R. Paul Guillerman, Allen Buxton, Scott C. Howard, (unknown), Andrea M. Sheehan, Dolores López‐Terrada, (unknown), (unknown), Meng‐Fen Wu, Hao Liu, Pedro A. de Alarcón, (unknown), Cindy L. Schwartz	22
12	Survivin-specific T cell receptor targets tumor but not T cells 2014 ·Journal of Clinical Investigation ·Caroline Arber, Xiang Feng, Harshal Abhyankar, (unknown), Meng‐Fen Wu, Helen E. Heslop, Patrick Barth, Gianpietro Dotti, Barbara Savoldo	55
13	Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins breakdown → 2013 ·Journal of Clinical Oncology ·Catherine M. Bollard, Stephen Gottschalk, Vicky Torrano, Oumar Diouf, Stephanie Ku, Yasmin Hazrat, George Carrum, Carlos A. Ramos, Luis Fayad, Elizabeth J. Shpall, Barbara Pro, Hao Liu, Meng‐Fen Wu, Daniel Lee, Andrea M. Sheehan, Youli Zu, Adrian P. Gee, Malcolm K. Brenner, Helen E. Heslop, Cliona M. Rooney	384
14	Analysis of NF-κB Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study 2012 ·PubMed ·Terzah M. Horton, Andrea M. Sheehan, Dolores López‐Terrada, R. Hutchison, (unknown), Meng‐Fen Wu, Hao Liu	2
15	Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients 2008 ·Blood ·Chrystal U. Louis, Karin Straathof, Catherine M. Bollard, Claudia Gerken, M. Helen Huls, (unknown), Meng‐Fen Wu, Heidi L. Weiss, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Stephen Gottschalk	83
16	Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer 2007 ·Blood ·Catherine M. Bollard, Stephen Gottschalk, Ann M. Leen, Heidi L. Weiss, Karin Straathof, George Carrum, Mariam Khalil, Meng‐Fen Wu, M. Helen Huls, Chung-Che Chang, (unknown), Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop	213

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact